The FSIS will not hold companies in noncompliance if they use the FDA label during the rulemaking period as long as the information is truthful and not misleading.
December 22, 2016
The FSIS will not hold companies in noncompliance if they use the FDA label during the rulemaking period as long as the information is truthful and not misleading.